Epstein-barr virus associated lymphoma and Thrombocytopenia

Summary:

Thrombocytopenia is found among people with Epstein-barr virus associated lymphoma, especially for people who are male, 50-59 old.

The study analyzes which people have Thrombocytopenia with Epstein-barr virus associated lymphoma. It is created by eHealthMe based on reports of 17 people who have Epstein-barr virus associated lymphoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Epstein-barr virus associated lymphoma?

Epstein-barr virus associated lymphoma (epstein-barr virus associated tumour) is found to be associated with 33 drugs and 101 conditions by eHealthMe. Check the latest studies of Epstein-barr virus associated lymphoma.

What is Thrombocytopenia?

Thrombocytopenia (decrease of platelets in blood) is found to be associated with 2,793 drugs and 4,869 conditions by eHealthMe. Check the latest studies of Thrombocytopenia.

On Jul, 08, 2026

17 people who have Epstein-Barr Virus Associated Lymphoma and Thrombocytopenia are studied.

Would you have Thrombocytopenia when you have Epstein-barr virus associated lymphoma?

Gender of people who have Epstein-Barr Virus Associated Lymphoma and experienced Thrombocytopenia *:

female: 9.09 %
male: 90.91 %

Age of people who have Epstein-Barr Virus Associated Lymphoma and experienced Thrombocytopenia *:

Common co-existing conditions for these people *:

Ventricular Arrhythmia (problem with the rate or rhythm of the heartbeat): 11 people, 64.71%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 11 people, 64.71%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 9 people, 52.94%
Burkitt Lymphoma (cancer of the lymphatic system): 9 people, 52.94%
Acute Kidney Failure: 8 people, 47.06%
Metastatic Lymphoma (spreadable cancer tumour of lymph node): 2 people, 11.76%
Hodgkin's Lymphoma (cancer originating from white blood cells): 2 people, 11.76%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 11.76%
Epstein-Barr Virus Associated Lymphoproliferative Disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus): 1 person, 5.88%

Common drugs taken by these people *:

Cyclophosphamide: 14 people, 82.35%
Prednisone: 11 people, 64.71%
Prednisolone: 11 people, 64.71%
Nadolol: 11 people, 64.71%
Cyclosporine: 11 people, 64.71%
Everolimus: 11 people, 64.71%
Vincristine Sulfate: 9 people, 52.94%
Mycophenolate Mofetil: 8 people, 47.06%
Atenolol: 7 people, 41.18%
Doxorubicin Hydrochloride: 6 people, 35.29%

Common symptoms for these people *:

Bone Pain: 12 people, 70.59%
Tachyphylaxis (a medical term describing an acute (sudden) decrease in the response to a drug after its administration): 10 people, 58.82%
Drug Ineffective: 9 people, 52.94%
Death: 8 people, 47.06%
Disease Progression: 8 people, 47.06%
Anaemia (lack of blood): 2 people, 11.76%
Neuropathy Peripheral (surface nerve damage): 2 people, 11.76%
White Blood Cell Count Decreased: 1 person, 5.88%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 5.88%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Thrombocytopenia?

- Check whether Thrombocytopenia is associated with a drug or a condition

Related publications that referenced our studies

YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .

Related studies:

Treatments, associated drugs and conditions:

Epstein-barr virus associated lymphoma (718 reports)
Thrombocytopenia (285,083 reports)

All the drugs that are associated with Thrombocytopenia:

Thrombocytopenia (2,793 drugs)

All the conditions that are associated with Thrombocytopenia:

Thrombocytopenia (4,869 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Thrombocytopenia and Epstein-barr virus associated lymphoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.